PRINCETON, N.J., June 3 /PRNewswire/ -- Celator Pharmaceuticals reported positive results from its CPX-1 Phase 2 clinical trial in patients with advanced colorectal cancer. CPX-1 is a liposomal ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** My first experience working with ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** SCCY has announced the new CPX Red ...
PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 ...
Celator Pharmaceuticals announced that the first patient has been treated in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection ...
1st Cavalry Division Headquarters Staff and 3rd Cavalry Regiment trained together in a joint command post exercise from Feb. 28 through Mar. 4, at Fort Hood. “This week, the Division is keenly focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results